In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying targeted hormonal treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide.
Challenges in Growth Hormone Therapy. The area of growth hormone therapy has been shrouded in controversy for several years. In the US, anxious parents apply pressure on doctors so their little ones can receive this elixir, regardless of whether there is a medical condition to treat. More recently, health care organizations have balked at the very high cost of growth hormone therapy, and with a greater consciousness of evidence-based medicine, there is also growing concerns about its efficacy. There are now fears about the safety of long-term growth hormone administration with possible risks of increased cardiovascular disease and diabetes, although the latter seems to be a temporary phenomenon. At the clinical level there are also uncertainties about proper optimum dosing schedules used for both children and adults, as well as how to manage the transition from childhood to adulthood (when to stop giving the hormone and how to follow up). Challenges in Growth Hormone Therapy tackles these issues and provides a timely and controversial review of these topics for endocrinologists and pediatricians.
Doctor Seibel talks about Hormone Therapy in Menopause. The site contains health videos, books and podcasts that teach about hot flashes, vaginal dryness, painful sex, estrogen therapy and other menopause symptoms.